Sumitomo Chemical Company's (TSE:4005) Promising Earnings May Rest On Soft Foundations

Sumitomo Chemical Company, Limited's (TSE:4005) robust earnings report didn't manage to move the market for its stock. We did some digging, and we found some concerning factors in the details.

earnings-and-revenue-history
TSE:4005 Earnings and Revenue History June 27th 2025
Advertisement

The Impact Of Unusual Items On Profit

For anyone who wants to understand Sumitomo Chemical Company's profit beyond the statutory numbers, it's important to note that during the last twelve months statutory profit gained from JP¥55b worth of unusual items. While it's always nice to have higher profit, a large contribution from unusual items sometimes dampens our enthusiasm. When we crunched the numbers on thousands of publicly listed companies, we found that a boost from unusual items in a given year is often not repeated the next year. And that's as you'd expect, given these boosts are described as 'unusual'. Sumitomo Chemical Company had a rather significant contribution from unusual items relative to its profit to March 2025. As a result, we can surmise that the unusual items are making its statutory profit significantly stronger than it would otherwise be.

That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.

Our Take On Sumitomo Chemical Company's Profit Performance

As we discussed above, we think the significant positive unusual item makes Sumitomo Chemical Company's earnings a poor guide to its underlying profitability. For this reason, we think that Sumitomo Chemical Company's statutory profits may be a bad guide to its underlying earnings power, and might give investors an overly positive impression of the company. The good news is that it earned a profit in the last twelve months, despite its previous loss. The goal of this article has been to assess how well we can rely on the statutory earnings to reflect the company's potential, but there is plenty more to consider. With this in mind, we wouldn't consider investing in a stock unless we had a thorough understanding of the risks. Case in point: We've spotted 3 warning signs for Sumitomo Chemical Company you should be mindful of and 1 of them shouldn't be ignored.

This note has only looked at a single factor that sheds light on the nature of Sumitomo Chemical Company's profit. But there is always more to discover if you are capable of focussing your mind on minutiae. Some people consider a high return on equity to be a good sign of a quality business. So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks with high insider ownership.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About TSE:4005

Sumitomo Chemical Company

Engages in Agro & Life Solutions, ICT & Mobility Solutions, Advanced Medical Solutions, Essential & Green Materials, and Sumitomo Pharma.

Good value with proven track record and pays a dividend.

Advertisement

Weekly Picks

LO
Lou_Basenese
CUE logo
Lou_Basenese on Cue Biopharma ·

Cue Biopharma (NASDAQ: CUE): The Scientist Behind Xolair Just Gave Cue a Next-Generation Shot at the Same Multi-Billion-Dollar Market

Fair Value:US$7065.0% undervalued
41 users have followed this narrative
0 users have commented on this narrative
8 users have liked this narrative
HA
HarishPK
ADBE logo
HarishPK on Adobe ·

Adobe: A Probabilistic Case for Undervaluation

Fair Value:US$319.9636.2% undervalued
45 users have followed this narrative
8 users have commented on this narrative
14 users have liked this narrative
NI
niteco
AVGO logo
niteco on Broadcom ·

A Capital Allocation Favorite with Structural Importance

Fair Value:US$651.0541.3% undervalued
43 users have followed this narrative
0 users have commented on this narrative
8 users have liked this narrative
TO
Tokyo
OKTA logo
Tokyo on Okta ·

Good foundation, but now it's all about the next steps

Fair Value:US$15123.0% undervalued
90 users have followed this narrative
7 users have commented on this narrative
11 users have liked this narrative

Updated Narratives

DC
DOCS logo
Dc12 on Doximity ·

High physician usership and impressive AI tools

Fair Value:US$33.740.5% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
RO
Rog
CTT logo
Rog on CTT - Correios De Portugal ·

Why CTT benefits in multiple ways right now

Fair Value:€6.6710.2% undervalued
0 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
ES
HSY logo
Esteban on Hershey ·

Hershey - fortress brand-and-scale position in U.S. confectionery: protects the downside far better than it compounds the upside

Fair Value:US$85.86111.6% overvalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

MA
martinarauz
NU logo
martinarauz on Nu Holdings ·

Investment Analysis (May 2026)

Fair Value:US$22.7446.4% undervalued
65 users have followed this narrative
0 users have commented on this narrative
15 users have liked this narrative
CL
Clive_Thompson
TTWO logo
Clive_Thompson on Take-Two Interactive Software ·

Take-Two Interactive: The Calm Before the Storm NASDAQ: TTWO Last Price: $242.41 Date: May 15, 2026

Fair Value:US$276.9723.5% undervalued
58 users have followed this narrative
0 users have commented on this narrative
14 users have liked this narrative
NI
niteco
HON logo
niteco on Honeywell International ·

Honeywell - The Demand-Side of the AI Infrastructure

Fair Value:US$320.1931.2% undervalued
49 users have followed this narrative
0 users have commented on this narrative
19 users have liked this narrative